Opinion

Video

Atopic dermatitis Clinical Trial Endpoints

An atopic dermatitis expert discusses the primary and secondary efficacy endpoints and treatment goals commonly assessed in clinical trials for moderate to severe atopic dermatitis.

  1. Please share primary and secondary efficacy outcomes/treatment targets routinely examined in atopic dermatitis clinical trials for moderate to severe atopic dermatitis.
  2. Is there consensus amongst experts on treatment targets? 
Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.